-
Posted by
Two Blokes Apr 30 -
Filed in
Stock
-
1 view
Shares in Genus PLC (LSE:GNS) surged 22% on Wednesday after the US Food and Drug Administration approved the company's gene-edited pigs for use in the American food supply. It marks a major breakthrough for the FTSE 250 animal genetics group, which has spent years developing pigs resistant to PRRS, a disease that has long plagued the global pork industry.
